166 related articles for article (PubMed ID: 28979682)
1. Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells.
Gu CJ; Cheng J; Zhang B; Yang SL; Xie F; Sun JS; Huang LQ; Yu JJ; Li MQ
Am J Transl Res; 2017; 9(9):4071-4082. PubMed ID: 28979682
[TBL] [Abstract][Full Text] [Related]
2. The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity.
Zhang B; Zhou WJ; Gu CJ; Wu K; Yang HL; Mei J; Yu JJ; Hou XF; Sun JS; Xu FY; Li DJ; Jin LP; Li MQ
Cell Death Dis; 2018 May; 9(5):574. PubMed ID: 29760378
[TBL] [Abstract][Full Text] [Related]
3. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside metabolite 20(S)‑protopanaxadiol promotes neural stem cell transition from a state of proliferation to differentiation by inducing autophagy and cell cycle arrest.
Chen S; He J; Qin X; Luo T; Pandey A; Li J; Liu S; Luo J; Wang Q; Luo Z
Mol Med Rep; 2020 Jul; 22(1):353-361. PubMed ID: 32319663
[TBL] [Abstract][Full Text] [Related]
5. 20(S)-Protopanaxadiol from
Song C; Shen T; Kim HG; Hu W; Cho JY
Am J Chin Med; 2023; 51(1):205-221. PubMed ID: 36408728
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
7. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
Zhang J; Zhang B; Yin Z; Chen F; Liu T; Xu H; Liu Y; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):932-7. PubMed ID: 25608995
[TBL] [Abstract][Full Text] [Related]
8. Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1.
Xue J; Li L; Li N; Li F; Qin X; Li T; Liu M
Eur J Pharmacol; 2019 Sep; 859():172541. PubMed ID: 31319067
[TBL] [Abstract][Full Text] [Related]
9. Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis.
Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
Cancer Cell Int; 2014; 14():53. PubMed ID: 24966801
[TBL] [Abstract][Full Text] [Related]
10. Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells.
Zhang J; Xu H; Zhou X; Li Y; Liu T; Yin X; Zhang B
Oncol Lett; 2017 Oct; 14(4):4949-4956. PubMed ID: 29085506
[TBL] [Abstract][Full Text] [Related]
11. Alteration of Panax ginseng saponin composition by overexpression and RNA interference of the protopanaxadiol 6-hydroxylase gene (CYP716A53v2).
Park SB; Chun JH; Ban YW; Han JY; Choi YE
J Ginseng Res; 2016 Jan; 40(1):47-54. PubMed ID: 26843821
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside 20(S)-protopanaxadiol induces cell death in human endometrial cancer cells via apoptosis.
Jo H; Jang D; Park SK; Lee MG; Cha B; Park C; Shin YS; Park H; Baek JM; Heo H; Brito S; Hwan HG; Chae S; Yan SW; Lee C; Min CK; Bin BH
J Ginseng Res; 2021 Jan; 45(1):126-133. PubMed ID: 33437164
[TBL] [Abstract][Full Text] [Related]
13. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
14. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
15. Metformin targeting autophagy overcomes progesterone resistance in endometrial carcinoma.
Zhuo Z; Wang A; Yu H
Arch Gynecol Obstet; 2016 Nov; 294(5):1055-1061. PubMed ID: 27402506
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside 20(S)-Protopanaxadiol Suppresses Viability of Human Glioblastoma Cells via Down-regulation of Cell Adhesion Proteins and Cell-cycle Arrest.
Wanderi C; Kim E; Chang S; Choi C; Choi K
Anticancer Res; 2016 Mar; 36(3):925-32. PubMed ID: 26976980
[TBL] [Abstract][Full Text] [Related]
18. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
Wang J; Shi H; Xie Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
[TBL] [Abstract][Full Text] [Related]
19. Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848.
Liu CY; Zhou RX; Sun CK; Jin YH; Yu HS; Zhang TY; Xu LQ; Jin FX
J Ginseng Res; 2015 Jul; 39(3):221-9. PubMed ID: 26199553
[TBL] [Abstract][Full Text] [Related]
20. Protopanaxadiol aglycone ginsenoside-polyethylene glycol conjugates: synthesis, physicochemical characterizations, and in vitro studies.
Mathiyalagan R; Kim YJ; Wang C; Jin Y; Subramaniyam S; Singh P; Wang D; Yang DC
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1803-1809. PubMed ID: 26539976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]